研究可吸入颗粒物在肺腺泡内的沉积规律对于明确肺气肿等常见呼吸系统疾病的诱因和发展，以及优化临床治疗和预防方案具有重要意义。本文建立了能够模拟终末细支气管和肺腺泡颗粒物沉积的体外实验模型，在不同功能残气量模式下研究了不同粒径的可吸入颗粒物在肺腺泡内的沉积率。结果表明，颗粒物直径是影响颗粒物在肺腺泡沉积的重要因素，1 μm 左右的颗粒物沉积率最高。功能残气量增大，颗粒物沉积率显著降低。本文研究结果为肺气肿和尘肺等疾病的靶向吸入治疗提供了数据支撑和优化途径，建立的模型也为研究可吸入颗粒物在肺腺泡内的沉积规律提供了一种可行的体外实验模型。
Research on the deposition of inhalable particles in the alveoli of the lungs is important to the causes, development for common respiratory diseases such as emphysema, and even the optimization of clinical treatment and prevention programs of them. In this paper, an in vitro experimental model was established to simulate the deposition of terminal bronchioles and pulmonary acinus particles. The deposition rate of inhalable particles with different particle sizes in the pulmonary acinus was studied under different functional residual capacity. The results showed that the particle diameter was an important factor affecting the deposition of particles in the lung alveoli. Particles with 1 μm diameter had the highest deposition rate. With the functional residual capacity increasing, particulate deposition rate significantly reduced. The results of this study may provide data support and optimization strategy for target inhalation therapy of respiratory diseases such as emphysema and pneumoconiosis. The established model may also provide a feasible in vitro experimental model for studying the deposition of inhalable particles in the pulmonary alveoli.
引用本文： 李蓉, 徐新喜, 乔杨, 赵秀国. 不同功能残气量对可吸入颗粒物在人体肺腺泡区沉积影响的实验研究. 生物医学工程学杂志, 2018, 35(4): 557-563. doi: 10.7507/1001-5515.201711054 复制